Medications for obesity management : Effectiveness and value
| Errataetall: |
ErratumIn: J Manag Care Spec Pharm. 2023 Jun;29(6):712. - PMID 37278446 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Journal of managed care & specialty pharmacy - 29(2023), 5 vom: 13. Mai, Seite 569-575 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Atlas, Steven J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 02.05.2023 Date Revised 01.08.2023 published: Print ErratumIn: J Manag Care Spec Pharm. 2023 Jun;29(6):712. - PMID 37278446 Citation Status MEDLINE |
|---|
| doi: |
10.18553/jmcp.2023.29.5.569 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356246442 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356246442 | ||
| 003 | DE-627 | ||
| 005 | 20231226070047.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18553/jmcp.2023.29.5.569 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1187.xml |
| 035 | |a (DE-627)NLM356246442 | ||
| 035 | |a (NLM)37121254 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Atlas, Steven J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Medications for obesity management |b Effectiveness and value |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.05.2023 | ||
| 500 | |a Date Revised 01.08.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumIn: J Manag Care Spec Pharm. 2023 Jun;29(6):712. - PMID 37278446 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anti-Obesity Agents |2 NLM | |
| 700 | 1 | |a Kim, Kibum |e verfasserin |4 aut | |
| 700 | 1 | |a Nhan, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Touchette, Daniel R |e verfasserin |4 aut | |
| 700 | 1 | |a Moradi, Ashton |e verfasserin |4 aut | |
| 700 | 1 | |a Agboola, Foluso |e verfasserin |4 aut | |
| 700 | 1 | |a Rind, David M |e verfasserin |4 aut | |
| 700 | 1 | |a Beaudoin, Francesca L |e verfasserin |4 aut | |
| 700 | 1 | |a Pearson, Steven D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of managed care & specialty pharmacy |d 2014 |g 29(2023), 5 vom: 13. Mai, Seite 569-575 |w (DE-627)NLM235806323 |x 2376-1032 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:5 |g day:13 |g month:05 |g pages:569-575 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18553/jmcp.2023.29.5.569 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 5 |b 13 |c 05 |h 569-575 | ||